Irisin has been reported to improve metabolic disorders by enhancing β‐cell function and insulin secretion in diabetes.[42, 43] Our results indicate reduced body weight and decreased blood glucose in hypoxia mouse models, whereas overexpression of irisin reverses the above changes to some extent. Here, INS is linked to diabetes mellitus.